A Molins

Summary

Affiliation: Massachusetts Institute of Technology
Country: USA

Publications

  1. doi Quantification of the benefit from integrating MEG and EEG data in minimum l2-norm estimation
    A Molins
    Harvard MIT Division for Health Sciences and Technology, Cambridge, MA 02139, USA
    Neuroimage 42:1069-77. 2008
  2. ncbi [Hyperammonemic encephalopathy associated with valproate acid]
    M T Osuna
    Seccion de Neurologia, Hospital Dr Josep Trueta Girona, Palma de Mallorca, Spain
    Neurologia 18:347-50. 2003
  3. ncbi [Levetiracetam in the treatment of epilepsy in adults. Experience with monotherapy]
    A Molins
    Unidad de Epilespsia, Servicio de Neurologia, Hospital Dr Josep Trueta, 17007 Girona, Espana
    Rev Neurol 45:331-3. 2007

Detail Information

Publications3

  1. doi Quantification of the benefit from integrating MEG and EEG data in minimum l2-norm estimation
    A Molins
    Harvard MIT Division for Health Sciences and Technology, Cambridge, MA 02139, USA
    Neuroimage 42:1069-77. 2008
    ..The effect was apparent in all source locations, with increased magnitude for deep areas such as the cingulate cortex. We were also able to corroborate the results for the somatosensory cortex using median nerve responses...
  2. ncbi [Hyperammonemic encephalopathy associated with valproate acid]
    M T Osuna
    Seccion de Neurologia, Hospital Dr Josep Trueta Girona, Palma de Mallorca, Spain
    Neurologia 18:347-50. 2003
    ..In order to obtain the correct diagnosis of HE, in all patients treated with either VPA mono or polytherapy, ammonium levels should be considered...
  3. ncbi [Levetiracetam in the treatment of epilepsy in adults. Experience with monotherapy]
    A Molins
    Unidad de Epilespsia, Servicio de Neurologia, Hospital Dr Josep Trueta, 17007 Girona, Espana
    Rev Neurol 45:331-3. 2007
    ..Levetiracetam (LEV) is an antiepileptic drug recently approved in monotherapy. AIM. To describe the characteristics and the outcome of a population of patients treated with LEV in monotherapy in clinical practice...